BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30168238)

  • 1. A stable meta-carborane enables the generation of boron-rich peptide agonists targeting the ghrelin receptor.
    Worm DJ; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Koebberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Pept Sci; 2018 Oct; 24(10):e3119. PubMed ID: 30168238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Selective Carborane-Functionalized Gastrin-Releasing Peptide Receptor Agonist as Boron Delivery Agent for Boron Neutron Capture Therapy.
    Hoppenz P; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Lerchen HG; Köbberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Org Chem; 2020 Feb; 85(3):1446-1457. PubMed ID: 31813224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Neuropeptide Y Conjugates with Maximized Carborane Loading as Promising Boron Delivery Agents for Boron Neutron Capture Therapy.
    Worm DJ; Hoppenz P; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Köbberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Med Chem; 2020 Mar; 63(5):2358-2371. PubMed ID: 31589041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of cyclic RGD-boron cluster conjugates to develop tumor-selective boron carriers for boron neutron capture therapy.
    Kimura S; Masunaga S; Harada T; Kawamura Y; Ueda S; Okuda K; Nagasawa H
    Bioorg Med Chem; 2011 Mar; 19(5):1721-8. PubMed ID: 21315608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular delivery and passive tumor targeting of a self-assembled nanogel containing carborane clusters for boron neutron capture therapy.
    Kawasaki R; Sasaki Y; Akiyoshi K
    Biochem Biophys Res Commun; 2017 Jan; 483(1):147-152. PubMed ID: 28039054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Self-Forming Nanosized DDS Particles for BNCT: Utilizing A Hydrophobic Boron Cluster and Its Molecular Glue Effect.
    Fithroni AB; Kobayashi K; Uji H; Ishimoto M; Akehi M; Ohtsuki T; Matsuura E
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-mediated uptake of boron-rich neuropeptide y analogues for boron neutron capture therapy.
    Ahrens VM; Frank R; Boehnke S; Schütz CL; Hampel G; Iffland DS; Bings NH; Hey-Hawkins E; Beck-Sickinger AG
    ChemMedChem; 2015 Jan; 10(1):164-72. PubMed ID: 25338544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid-decorated carborane-TAT conjugation nanomicelles: A potential boron agent with enhanced selectivity of tumor cellular uptake.
    Quan H; Fan L; Huang Y; Xia X; He Y; Liu S; Yu J
    Colloids Surf B Biointerfaces; 2021 Aug; 204():111826. PubMed ID: 33984611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model.
    Iguchi Y; Michiue H; Kitamatsu M; Hayashi Y; Takenaka F; Nishiki T; Matsui H
    Biomaterials; 2015 Jul; 56():10-7. PubMed ID: 25934274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-targeting hyaluronic acid/fluorescent carborane complex for boron neutron capture therapy.
    Yamana K; Kawasaki R; Sanada Y; Tabata A; Bando K; Yoshikawa K; Azuma H; Sakurai Y; Masunaga SI; Suzuki M; Sugikawa K; Nagasaki T; Ikeda A
    Biochem Biophys Res Commun; 2021 Jun; 559():210-216. PubMed ID: 33957482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy.
    Meo CD; Panza L; Capitani D; Mannina L; Banzato A; Rondina M; Renier D; Rosato A; Crescenzi V
    Biomacromolecules; 2007 Feb; 8(2):552-9. PubMed ID: 17291079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrophobic boron compound-loaded poly(l-lactide-co-glycolide) nanoparticles for boron neutron capture therapy.
    Takeuchi I; Nomura K; Makino K
    Colloids Surf B Biointerfaces; 2017 Nov; 159():360-365. PubMed ID: 28806667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boron rich nanotube drug carrier system is suited for boron neutron capture therapy.
    Heide F; McDougall M; Harder-Viddal C; Roshko R; Davidson D; Wu J; Aprosoff C; Moya-Torres A; Lin F; Stetefeld J
    Sci Rep; 2021 Jul; 11(1):15520. PubMed ID: 34330984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of core-polymerized, boron-conjugated micelles designed for boron neutron capture therapy for cancer.
    Sumitani S; Oishi M; Yaguchi T; Murotani H; Horiguchi Y; Suzuki M; Ono K; Yanagie H; Nagasaki Y
    Biomaterials; 2012 May; 33(13):3568-77. PubMed ID: 22326646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of boron containing monosaccharides by the hydroboration of d-glucal for use in boron neutron capture therapy (BNCT).
    Itoh T; Tamura K; Ueda H; Tanaka T; Sato K; Kuroda R; Aoki S
    Bioorg Med Chem; 2018 Dec; 26(22):5922-5933. PubMed ID: 30420329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boron neutron capture therapy of cancer: current status and future prospects.
    Barth RF; Coderre JA; Vicente MG; Blue TE
    Clin Cancer Res; 2005 Jun; 11(11):3987-4002. PubMed ID: 15930333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.
    Altieri S; Balzi M; Bortolussi S; Bruschi P; Ciani L; Clerici AM; Faraoni P; Ferrari C; Gadan MA; Panza L; Pietrangeli D; Ricciardi G; Ristori S
    J Med Chem; 2009 Dec; 52(23):7829-35. PubMed ID: 19954249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carborane-Containing Folic Acid
    Gruzdev DA; Telegina AA; Levit GL; Solovieva OI; Gusel'nikova TY; Razumov IA; Krasnov VP; Charushin VN
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One stone kills three birds: novel boron-containing vesicles for potential BNCT, controlled drug release, and diagnostic imaging.
    Chen G; Yang J; Lu G; Liu PC; Chen Q; Xie Z; Wu C
    Mol Pharm; 2014 Oct; 11(10):3291-9. PubMed ID: 24521224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy.
    Shukla S; Wu G; Chatterjee M; Yang W; Sekido M; Diop LA; Müller R; Sudimack JJ; Lee RJ; Barth RF; Tjarks W
    Bioconjug Chem; 2003; 14(1):158-67. PubMed ID: 12526705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.